Clinical Trial Update: Safety and Efficacy of Hypothermia to Treat Neonatal Hypoxic-Ischemic Encephalopathy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the safety and efficacy of therapeutic hypothermia to treat neonatal hypoxic-ischemic encephalopathy. Results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Therapeutic hypothermia

Snippet

Sponsor: Fudan University | Conditions: Hypoxic-Ischemic Encephalopathy | Phase 3 | Status: COMPLETED | Results posted: 2009-04-29